IP Library Granted Patent US 9,486,481
Granted Patent B2
US 9,486,481 · App. 14/021,329 · Granted Nov 8, 2016

Method of modulating fatty acid mobilization and oxidation

Inventors: David Nieman (Weaverville, NC); Bristol Sorensen (San Leandro, CA)
Assignee: Reoxcyn Discoveries Group, Inc.
A61K33/40A61K33/00A61K33/14A61K33/20A61K45/06G01N33/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,486,481
App. No.
14/021,329
Granted
Nov 8, 2016
Kind
B2
Abstract

Methods of mobilizing fatty acids are disclosed.

Claims (8)

1. A method for mobilizing fatty acids in a subject with a composition comprising redox-signaling molecules, the method comprising:

providing a subject;

preparing a composition comprising a mixture of reduced species (RS) and reactive oxygen species (ROS) by electrolyzing a circulating saline solution to produce the mixture of reduced species (RS) and reactive oxygen species (ROS) wherein the mixture of reduced species and reactive oxygen species mobilizes the fatty acids in a subject;

administering the composition to the subject;

exercising the subject; and

verifying increased mobilization of fatty acids in the subject by measuring biochemical markers related to mobilization of fatty acids in the subject.

2. The method of claim 1 , wherein the biochemical markers comprise one or more of 1-palmitoylglycerophosphoethanolamine, 1-oleoylglycerophosphoethanolamine, 1-stearoylglycerophosphoethanolamine, 1-arachidonoylglycerophosphoethanolamine, 1-palmitoylglycerophosphoinositol, 1,3-dipalmitoylglycerol, 1-oleoylglycerophosphoinositol, 2-linoleoylglycerophosphoethanolamine, 1-palmitoylglycerol (1-monopalmitin), 1-stearoyl glycerol (1-monostearin), glycerol, myristate, palmitate, palmitoleate, oleate, decanoylcarnitine, palmitoylcarnitine, acetoacetate, 3-hydroxybutyrate (BHBA, eicosapentaenoate, linoleate, stearidonate, trans-4-hydroxyporoline, urate, 7-methylguanine, N2,N2-dimethylguanosine, xanthine, and hypoxanthine.

3. The method of claim 1 , wherein administering the composition comprises administering four ounces of the composition daily to the subject for at least two weeks prior to exercising the subject.

Assignments (2)
CHANGE OF NAME Recorded Jun 18, 2019
From: REOXCYN DISCOVERIES GROUP, INC.
To: RDG HOLDINGS, INC.
Reel/Frame 049511/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2016
From: NIEMAN, DAVID; SORENSEN, BRISTOL
To: REOXCYN DISCOVERIES GROUP, INC.
Reel/Frame 039783/0722 →
Continuity (11)
Continuation In Part 13857225 · Apr 5, 2013
Continuation In Part 12592402 · Nov 24, 2009
Continuation In Part 12383212 · Mar 20, 2009
Continuation In Part 12290398 · Oct 30, 2008
Continuation In Part 14021329
Continuation In Part 13857882 · Apr 5, 2013
Continuation In Part 12592402 · Nov 24, 2009
Continuation In Part 12383212 · Mar 20, 2009
Continuation In Part 12290398 · Oct 30, 2008
Provisional Application 61001010 · Oct 30, 2007
Related Publication 20140056991A1 · Feb 27, 2014